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mechanisms: tubular obstruction or crescent-like glomerular epi-
thelial hyperplasia causing compression of the tuft. Renal function
impairment in adult mice correlated with the severity of the
morphologic renal abnormalities and led to terminal renal failure
by few months of age.
Studies of the transgene expression showed strong expression in
the kidneys and weak or no detectable expression in other organs.
By in situ hybridization analysis, transgene expression was con-
fined to the renal cystic and hyperplastic tubular epithelium in
adult mice, whereas in fetal mice the signal was also detected over
the parietal and visceral epithelium of glomerular cysts.
Definite proof that the SBM transgene is responsible for the
PKD phenotype was obtained by the identification of in vivo
mouse revertants. During the course of continuous breeding of
eight SBM transgenic lines, mice from all these lines underwent
spontaneous mutations consisting of deletions and/or rearrange-
ment of the transgene. A high frequency of spontaneous deletion
of part of the SBM gene was observed in several lines. This high
frequency of mutation appears unrelated to the transgene copy
number or to the site of integration. Revertant mice and their
progeny had no evidence of a renal disease, were healthy and lived
a normal lifespan. This study provides proof that the intact SBM
transgene is necessary and sufficient to produce a PKD pheno-
type.
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Role of growth factors in cell proliferation
E.D. Avner, WE. Sweeney, and S. Orellana
University of Washington School of Medicine, Seattle, Washington, USA
Over the past five years a variety of polypeptide growth factors
have been implicated in the altered cellular proliferation which
accompanies renal tubular cyst formation and progressive en-
largement. Attention has particularly focused on the EGF/TGFa/
EGFR axis in mediating tubular cyst formation. Studies over the
last five years in a number of laboratories have determined that:
(1) EGF and TGFa are cystogenic in vitro; (2) cystic renal tissue
has decreased preproEGF and EGF concentrations but increased
expression of TGFa and EGFR; and (3) renal cyst fluid contains
bioactive and immuoreactive EGF peptides in mitogenic concen-
trations. We have thus chosen to study specific abnormalities of
the EGFR in experimental murine models of ARPKD.
During murine nephrogenesis EGF receptor expression has a
distinct developmental profile by Western analysis. During pro-
gressive stages (newborn through day 21 postnatal) of tubular
cystogenesis in the cpk mouse, EGFR expression was significantly
greater than in matched controls. By immunohistological analysis,
EGFR was present in epithelial basolateral cell membranes in
control collecting tubules, and all but a small population of
immature proximal tubules, at all stages of nephrogenesis. This
contrasts with our previously described pattern of apical-lateral
Na/K ATPase expression during early collecting tubule formation.
While EGFR was expressed basolaterally in cpk proximal tubular
cysts, it was expressed apically as well as basolaterally in the
majority of cystic cpk collecting tubules. The aberrant pattern of
apical EGFR expression was also seen in collecting tubules from
all murine models of collecting tubular cystogenesis currently
under study in our laboratory, as well as in tissue obtained from
patients with ARPKD. To determine whether quantitative and
qualitative abnormalities in EGFR expression were mediated at
the transcription level, steady-state EGFR mRNA expression was
determined at distinct developmental stages in control and cpk
kidneys. Mouse EGFR cDNA was cloned by reverse transcription
of control kidney mRNA followed by PCR amplification. eDNA
was used to generate a specific riboprobe for EGFR mRNA
detection by Northern analysis. Control and cpk kidneys expressed
the same species of EGFR mRNA, ruling out the possibility that
an abnormally spliced variant leads to the production of an
abnormally sorted protein. However, levels of EGFR mRNA
constantly increased with age in cpk kidneys, while remaining
constant in progressive age-matched controls. These data suggest
that there is complex regulation of the EGFR in cystic tubule
epithelium at both the transcriptional and post-transcriptional
levels which may be cell specific. EGFR mislocation and over-
expression may be a mechanism whereby EGF-like factors in
cyst fluid stimulate cellular proliferation through an autocrine-
paracrine cycle in ARPKD.
To participate in such a proposed autocrine-paracrine cycle of
proliferation, apical EGFRs must be able to bind ligand, trans-
duce a signal, and mediate altered proliferation. To identify the
possible physiological significance of apical EGFR expression in
murine models, collecting tubular epithelial cells were isolated
from control and cystic kidneys by direct tubule or cyst microdis-
section followed by selective lectin sorting. DBA positive collect-
ing tubule cells from controls demonstrated mature principle cell
ultrastructural features and basal cell membrane localization of
EGFR. In contrast, DBA positive collecting tubule cells from cpk
cysts demonstrated immature principle cell ultrastructure and
apical expression of EGFR. By Western analysis cpk collecting
tubular cells had increased EGFR. Both control and cpk CT cells
maintain their distinct EGFR expression patterns through at least
10 passages. While both control and cystic collecting tubules
demonstrated similar growth profiles under control conditions,
cpk collecting tubular cells demonstrated a significantly increased
mitogenic response to EGFR supplementation of culture medium
when assessed by tritiated thymidine uptake. Additional studies
were performed on control and cystic collecting tubule popula-
tions grown on culture membrane inserts which permit experi-
mental isolation of apical and basal cell surfaces. Binding of
biotinylated EGF applied to apical cell surfaces was significantly
increased in cpk versus control collecting tubules. In addition,
studies of tyrosine phosphoiylation of the EGFR utilizing immu-
noprecipitation with anti-EGFR followed by Western analysis
with anti-phosphotyrosine antibodies revealed the presence of
phosphorylated EGFR in cpk but not control collecting tubular
cells following application of EGF to apical cell surfaces. On
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balance, these studies demonstrate that the apically mislocated
EGFR in cpk collecting tubular cells binds EGF, and functions as
a tyrosine kinase. Further, altered quantitative and qualitative
EGFR expression correlated directly with hyperresponsiveness to
the mitogenic actions in vivo.
Such data have relevance to treatment of cyst formation and
progressive enlargement in PKD. In vitro application of specific
blocking antiEGFR antibodies or tyrphostins block the cystogenic
effects of EGF and TGFa. It is also possible that manipulation of
the EGFR promoter activity could lead to the development of
sophisticated delivery systems which might target such activities to
cystic renal epithelium.
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II. ABNORMAL TRANSPORT BY EPITHELIAL CELLS
CVFR: Cloning, mutations and functions
J.R. Riordan
Hospital for Sick Children, Toronto, Ontario, Canada
CFTR, the product of the gene which when mutated causes
cystic fibrosis, is involved in both chloride secretion and absorp-
tion in some epithelia, for example, in the shark rectal gland which
is a prototype of the former process, and in the reabsorptive duct
of the sweat gland, which is representative of the latter. The major
disease-causing mutation (SF508) was initially identified in that
tissue. The use of N-glycosylation sites inserted at various posi-
tions in the sequence by in vitro mutagenesis has recently con-
firmed the original topological model in which there are six
membrane-spanning segments in each half of the protein. This,
together with mutagenesis of specific residues in many of these
segments, strongly suggest that they assemble in some manner to
form the ion pore. CFTR is a substrate for multiple protein
kinases, phosphatases and eleven protein kinase A (PKA) phos-
phorylation sites. These account for the activation in excised
membrane patches by ATP and PKA. This level of regulation is
integrated with another level involving interactions of ATP at the
nucleotide binding folds (NBFs) in each half of the molecule. In
addition to this extremely complex regulatory mechanism, CFTR
is distinctive in that it is biosynthetically unstable, that is, conver-
sion of the nascent polypeptide to a mature folded and post-
translationally modified form which can be transported to the cell
surface occurs with very low inefficiency (—20%). Mutations at
many sites in the molecule, including zF508 exacerbate this
behavior and no mature protein is formed. We have recently
demonstrated that a resident chaperone of the endoplasmic
reticulum (ER), calnexin, contributes to the quality control mech-
anism which retains the immature form in the ER where it is
degraded; other chaperones also participate in the biosynthetic
maturation of CFTR.
Solute and fluid secretion mechanisms in intestinal and airway
epithelial cells
R.A. Frizzell, M Howard, M.D. DuVall, and A.P. Morris
University of Alabama, Birmingham, Alabama, USA
Since the cloning of the gene responsible for cystic fibrosis,
tremendous progress has been made in understanding its function
as a cAMP-regulated Cl channel. In concert with other transport
mechanisms, this apical membrane Cl channel mediates cAMP-
dependent salt and water secretion across the epithelial cells of
airway and intestinal tissues. In CF patients who carry the zF508
mutation, the mutant protein is retained intracellularly and is not
targeted to the plasma membrane. Previous studies have shown
that the mutant protein is functional, thus approaches designed to
facilitate plasma membrane targeting of zF508 CFTR would
benefit the majority of CF patients. The mechanisms responsible
for retention of mutant protein within the ER are unknown.
Wild-type CFTR is involved in cAMP-dependent regulation of
vesicle recycling at the plasma membrane. Cells that express
wild-type CFFR show cAMP-induced activation of exocytosis and
inhibition of endocytosis. CFTR function in intracellular mem-
branes has been implicated in the degree of acidification of
various intracellular compartments of the protein processing and
secretory pathways. This represents a potential mechanism for
alterations in macromolecular secretory products or other trans-
port events.
Issues surrounding CFTR trafficking require a specific and
sensitive means of detecting the protein in cells and tissues. To
address this problem, we chose to epitope tag the CFTR protein
on one of the extracellular loops and at the C-terminus, with the
M2 epitope as a means of detecting the recombinant protein when
it was expressed. The externally tagged CVFR was detected in the
surface membrane of non-permeablized cells, and the percent of
cells stained by M2 epitope antibody correlated with their halide
permeability response to cAMP. Antibody labeling experiments
showed that surface CFTR was rapidly endocytosed under non-
stimulated conditions, cAMP inhibited CFTR endocytosis and
increased the plasma membrane content of CFTR about three-
fold. CFTR tagged at the C-terminus was expressed in Xenopus
oocytes. Frozen sections were prepared and stained using the M2
antibody. cAMP caused a condensation of fluorescence at the
plasma membrane with a time course similar to that observed for
stimulation of transmembrane Cl currents. These findings indicate
that cAMP-dependent membrane trafficking of CFTR contributes
to the chloride conductance response evoked by secretory ago-
nists. These tagged CFTRs should be useful for further studies of
CFTR trafficking and CFTR-protein interactions.
In cultured cells that express CFTR endogenously or after its
expression by gene transfer, CFTR has been localized to the
plasma membrane and shown to function as a cAMP-activated CI
channel. In primary cultures or cell lines that form an epithelial
monolayer, CFTR can be identified in the apical membrane
domain. This location fits with its role in transepithelial Cl
secretion. Small linear Cl channels are also found in the apical
